NO983777L - 3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater - Google Patents

3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater

Info

Publication number
NO983777L
NO983777L NO983777A NO983777A NO983777L NO 983777 L NO983777 L NO 983777L NO 983777 A NO983777 A NO 983777A NO 983777 A NO983777 A NO 983777A NO 983777 L NO983777 L NO 983777L
Authority
NO
Norway
Prior art keywords
carbon atom
amino
disubstituted
configuration
tetralinecarboxamide
Prior art date
Application number
NO983777A
Other languages
English (en)
Other versions
NO983777D0 (no
NO323095B1 (no
Inventor
Makio Kitazawa
Kosuke Okazaki
Tetsuro Tamai
Masaru Saito
Nobuyuki Tanaka
Hiroaki Kobayashi
Ken Kikuchi
Hideyuki Muranaka
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13386565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO983777(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO983777D0 publication Critical patent/NO983777D0/no
Publication of NO983777L publication Critical patent/NO983777L/no
Publication of NO323095B1 publication Critical patent/NO323095B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
NO19983777A 1996-02-19 1998-08-18 3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater NO323095B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6888596 1996-02-19
PCT/JP1997/000424 WO1997030023A1 (en) 1996-02-19 1997-02-18 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives

Publications (3)

Publication Number Publication Date
NO983777D0 NO983777D0 (no) 1998-08-18
NO983777L true NO983777L (no) 1998-10-19
NO323095B1 NO323095B1 (no) 2007-01-02

Family

ID=13386565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983777A NO323095B1 (no) 1996-02-19 1998-08-18 3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater

Country Status (24)

Country Link
US (1) US6133266A (no)
EP (1) EP0882704B1 (no)
JP (1) JP3892045B2 (no)
KR (1) KR100491633B1 (no)
CN (1) CN1100032C (no)
AT (1) ATE225767T1 (no)
AU (1) AU725042B2 (no)
BR (1) BR9707566B1 (no)
CA (1) CA2245490C (no)
CZ (1) CZ293974B6 (no)
DE (1) DE69716242T2 (no)
DK (1) DK0882704T3 (no)
EA (1) EA002143B1 (no)
ES (1) ES2184989T3 (no)
HU (1) HU229400B1 (no)
ID (1) ID16091A (no)
MY (1) MY123853A (no)
NO (1) NO323095B1 (no)
NZ (1) NZ331445A (no)
PL (1) PL186411B1 (no)
PT (1) PT882704E (no)
SG (1) SG72727A1 (no)
TW (1) TW375604B (no)
WO (1) WO1997030023A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009001A1 (fr) * 1997-08-19 1999-02-25 Kissei Pharmaceutical Co., Ltd. Derives de phenylethanolaminotetraline et bronchodilatateurs
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
FR2809725B1 (fr) * 2000-06-06 2004-05-07 Sanofi Synthelabo Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant
GB0029562D0 (en) 2000-12-04 2001-01-17 Novartis Ag Organic compounds
US20060052458A1 (en) * 2003-01-22 2006-03-09 Kissei Pharmaceutical Co., Ltd. Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
WO2006054514A1 (ja) * 2004-11-19 2006-05-26 Kissei Pharmaceutical Co., Ltd. 神経因性疼痛の予防又は治療用医薬組成物
EP1813285A4 (en) * 2004-11-19 2010-06-09 Kissei Pharmaceutical PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST NEUROPATHIC PAIN
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
JP2013511528A (ja) * 2009-11-18 2013-04-04 メディシノバ，インコーポレーテッド 喘息の急性憎悪の治療及びそれに罹患した患者の入院の可能性の低減
BR112012022619A2 (pt) * 2010-03-08 2015-10-20 Medicinova Inc composições, métodos, e meios para tratamento da dismenorreia
JP5841994B2 (ja) * 2010-04-08 2016-01-13 メディシノヴァ， インコーポレイテッド． 過敏性腸症候群の処置方法及びその治療用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107827D0 (en) * 1991-04-12 1991-05-29 Fujisawa Pharmaceutical Co New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL104567A (en) * 1992-02-03 1997-03-18 Fujisawa Pharmaceutical Co Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO1993018007A1 (fr) * 1992-03-13 1993-09-16 Tokyo Tanabe Company Limited Nouveau derive de carbostyrile

Also Published As

Publication number Publication date
KR100491633B1 (ko) 2005-09-09
PL186411B1 (pl) 2004-01-30
SG72727A1 (en) 2000-05-23
CN1216526A (zh) 1999-05-12
ID16091A (id) 1997-09-04
CZ293974B6 (cs) 2004-09-15
ES2184989T3 (es) 2003-04-16
BR9707566A (pt) 1999-07-27
NO983777D0 (no) 1998-08-18
EP0882704B1 (en) 2002-10-09
CN1100032C (zh) 2003-01-29
AU2001497A (en) 1997-09-02
EP0882704A4 (en) 2000-06-14
KR19990082638A (ko) 1999-11-25
EA002143B1 (ru) 2001-12-24
TW375604B (en) 1999-12-01
JP3892045B2 (ja) 2007-03-14
NZ331445A (en) 2000-01-28
BR9707566B1 (pt) 2010-08-10
HU229400B1 (en) 2013-12-30
WO1997030023A1 (en) 1997-08-21
CZ252398A3 (cs) 1998-12-16
EA199800644A1 (ru) 1999-02-25
MY123853A (en) 2006-06-30
CA2245490A1 (en) 1997-08-21
CA2245490C (en) 2005-10-25
HUP9900621A3 (en) 1999-11-29
AU725042B2 (en) 2000-10-05
DK0882704T3 (da) 2003-02-17
DE69716242T2 (de) 2003-07-24
DE69716242D1 (de) 2002-11-14
EP0882704A1 (en) 1998-12-09
US6133266A (en) 2000-10-17
HUP9900621A2 (hu) 1999-08-30
NO323095B1 (no) 2007-01-02
PT882704E (pt) 2003-02-28
PL328530A1 (en) 1999-02-01
ATE225767T1 (de) 2002-10-15

Similar Documents

Publication Publication Date Title
AU623733B2 (en) Benzofused-n-containing heterocyle derivatives
NO983777D0 (no) 3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
DE69713319D1 (de) 3,4-disubstituierte phenylethanolaminotetralincarboxylat-derivate
NO913023L (no) Nye bicykliske aminosubstituerte forbindelser
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
NO984699D0 (no) Fenyletanolamino-tetralinkarboks-amid-derivater
KR920008034A (ko) 항고혈압 작용 및 혈관 확장 활성있는 벤조피란 유도체, 그의 제법 및 그의 치료적 용도
GR3007498T3 (no)
EP0919233B8 (en) Therapeutic agent for kidney diseases
CA2251090A1 (en) Phenylethanolaminotetralincarboxamide derivatives
EP0420464A3 (en) 3-isoxazolone derivatives, their preparation and their therapeutic uses

Legal Events

Date Code Title Description
MK1K Patent expired